Long non-coding RNA OIP5-AS1 plays an oncogenic role in ovarian cancer through targeting miR-324-3p/NFIB axis

Q-Y Liu1, X-X Jiang, H-N Tian

  • 1Department of Gynaecology, Rizhao People's Hospital, Rizhao, China. hekesongkeng1598@163.com.

Abstract

Insights

Long non-coding RNA OIP5-AS1 accelerates ovarian cancer (OC) progression by sponging miR-324-3p and upregulating NFIB. This suggests OIP5-AS1 is a potential therapeutic target for OC treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Long non-coding RNAs (lncRNAs) play roles in ovarian cancer (OC) progression.
  • The specific functions of lncRNA-OIP5-AS1 in OC remain largely unexplored.

Purpose of the Study:

  • To investigate the molecular mechanisms of OIP5-AS1 in ovarian cancer.
  • To elucidate the role of OIP5-AS1 in OC progression and its potential as a therapeutic target.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) to assess expression levels of OIP5-AS1, miR-324-3p, and NFIB.
  • Cell viability, invasion, and migration assays (CCK-8, Transwell) to evaluate OC cell behavior.
  • Western blot analysis for NFIB protein levels and Dual-Luciferase reporter assay for molecular interactions.

Main Results:

  • OIP5-AS1 and NFIB were upregulated, while miR-324-3p was downregulated in OC tissues and cell lines.
  • OIP5-AS1 knockdown and miR-324-3p overexpression inhibited OC cell viability, invasion, and migration.
  • OIP5-AS1 was found to inhibit miR-324-3p, which directly targets NFIB, and NFIB silencing suppressed OC cell progression.

Conclusions:

  • OIP5-AS1 promotes OC progression by sponging miR-324-3p and upregulating NFIB.
  • OIP5-AS1 represents a potential therapeutic target for ovarian cancer treatment.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.6K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.7K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.5K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.1K